Guardion Health Sciences, Inc. Common Stock
GHSI
GHSI was delisted on the 11th of October, 2024.
8 hedge funds and large institutions have $556K invested in Guardion Health Sciences, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
827% more capital invested
Capital invested by funds: $60K → $556K (+$496K)
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
33% more funds holding
Funds holding: 6 → 8 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$635K |
| 2 |
Barclays
London,
United Kingdom
|
+$66.7K |
| 3 |
VF
Virtu Financial
New York
|
+$33.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$26.7K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$19K |
| 2 |
HF
HRT Financial
New York
|
-$668 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $439K | +$635K | +6,646 | New |
|
|
2
Barclays
London,
United Kingdom
| $46K | +$66.7K | +699 | New |
|
|
VF
3
Virtu Financial
New York
| $31K | +$33.7K | +353 | +310% |
|
|
4
UBS Group
Zurich,
Switzerland
| $20K | +$26.7K | +280 | +1,000% |
|
|
5
Vanguard Group
Malvern,
Pennsylvania
| $9K | +$13.4K | +140 | New |
|
|
PMG
6
Private Management Group
Irvine,
California
| $6K | +$8.4K | +88 | New |
|
7
BlackRock
New York
| $3K | +$3.92K | +41 | +2,050% |
|
|
HF
8
HRT Financial
New York
| $2K | -$668 | -7 | -17% |
|
|
TSS
9
Two Sigma Securities
New York
| – | -$19K | -83 | Closed |
|
GHSI Hedge Fund Activity: Q4 2019 in Review
8 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q4 2019, worth a combined $556K — up 827% from $60K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new GHSI positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $635K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $19K sold.
- 8 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q4 2019, up from 6 in Q3 2019.
- Funds reported $556K of Guardion Health Sciences, Inc. Common Stock stock for Q4 2019, up 827% quarter-over-quarter.
- 4 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q4 2019 and 2 closed out, a net change of +2 holders.
- The largest Guardion Health Sciences, Inc. Common Stock buyer in Q4 2019 was Sabby Management, an estimated $635K added.
- The largest Guardion Health Sciences, Inc. Common Stock seller in Q4 2019 was Two Sigma Securities, an estimated $19K sold.
Based on aggregated 13F filings for Q4 2019.